[Changes and significance of type 2 innate lymphoid cells and their related factors in bronchopulmonary dysplasia]. [PDF]
Wang QW, Zhu Y, Wang QX, Lu HY.
europepmc +1 more source
[Expert consensus on the follow-up management of bronchopulmonary dysplasia in preterm infants after discharge]. [PDF]
Neonatal Evidence-Based Medicine Group +2 more
europepmc +1 more source
Construction of early risk prediction models for bronchopulmonary dysplasia in preterm infants. [PDF]
Zhang R +7 more
europepmc +1 more source
[Risk factors for moderate/severe bronchopulmonary dysplasia in preterm infants with a gestational age of <32 weeks: a multicenter retrospective analysis]. [PDF]
Jiangsu Province Neonatal Perinatal Cooperation Network.
europepmc +1 more source
Recent research on the mechanism of mesenchymal stem cells in the treatment of bronchopulmonary dysplasia. [PDF]
Xie KJ, Dong MY, Bai JX.
europepmc +1 more source
[Influence of bronchopulmonary dysplasia on cerebral blood flow in preterm infants: a prospective study based on arterial spin labeling]. [PDF]
Zhang C +7 more
europepmc +1 more source
[Influencing factors for the development and severity of bronchopulmonary dysplasia in preterm infants with a gestational age of <32 weeks and a birth weight of <1 500 g]. [PDF]
Huang J, Lin XZ, Zheng Z, Wang L, Ou FF.
europepmc +1 more source
[A review on the effect of Claudin-18 on bronchopulmonary dysplasia in preterm infants]. [PDF]
Zuo JY, Tong YJ, Yue DM.
europepmc +1 more source
Efficacy and safety of intratracheal administration of budesonide combined with pulmonary surfactant in preventing bronchopulmonary dysplasia: a prospective randomized controlled trial. [PDF]
Liu MM, Ji L, Dong MY, Zhu XF, Wang HJ.
europepmc +1 more source
[Association of early nutrition deficiency with the risk of bronchopulmonary dysplasia: a Meta analysis]. [PDF]
Fang LY +4 more
europepmc +1 more source

